Kairos Pharma, Ltd. (KAPA) ownership: Top institutional holder: CITADEL ADVISORS LLC ($228434.00). SEC EDGAR first-party data.
| Holder | Shares | Market Value | Reported |
|---|---|---|---|
| CITADEL ADVISORS LLC | 321738.00 | $228434.00 | 2025-12-31 |
| VANGUARD CAPITAL MANAGEMENT LLC | 231878.00 | $129620.00 | 2026-03-31 |
| VANGUARD GROUP INC | 131828.00 | $93598.00 | 2025-12-31 |
| GEODE CAPITAL MANAGEMENT, LLC | 111290.00 | $62210.00 | 2026-03-31 |
| VANGUARD FIDUCIARY TRUST CO | 63884.00 | $35711.00 | 2026-03-31 |
| XTX Topco Ltd | 48494.00 | $34431.00 | 2025-12-31 |
| SevenBridge Financial Group, LLC | 44286.00 | $30331.00 | 2026-03-31 |
| Aptus Capital Advisors, LLC | 44286.00 | $24756.00 | 2026-03-31 |
Back to KAPA overview · KAPA earnings · All congressional trades
Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.